AI Summary
Middle East Pharmaceutical Industries Co.’s (Avalon Pharma) board of directors approved a 13.2% cash dividend, at SAR 1.32 per share, for H2 2025, the company said in a statement to Tadawul.
|
Dividend Details (H2 2025) |
|
|
Current Capital |
SAR 200 mln |
|
Number of Shares |
20 mln |
|
Total Dividend |
SAR 26.4 mln |
|
Percentage of Capital |
13.2% (SAR 1.32 per share) |
|
Record Date |
March 29, 2026 |
|
Payment Date |
April 7, 2026 |
|
Dividend Details (2025) |
|
|
Total Dividend |
SAR 48.4 mln |
|
Percentage of Capital |
24.2% (SAR 2.42 per share) |
| Announcement | Ex-Dividend | Payment | Dividends (M Riyal) | Dividends * | Notes |
| 08/03/2026 | 29/03/2026 | 07/04/2026 | 26.40 | 1.32 | |
| 13/08/2025 | 01/09/2025 | 15/09/2025 | 22.00 | 1.10 | |
| 13/04/2025 | 01/05/2025 | 15/05/2025 | 25.00 | 1.25 | |
| 30/07/2024 | 01/09/2024 | 15/09/2024 | 15.00 | 0.75 |
| Consolidated cash dividend | Cash dividend per share (SAR) | * The stock price at the beginning of the period (SAR) | Return on the base price |
|---|---|---|---|
| Last 3 Financial years | N/A | N/A | N/A |
| Last 5 Financial years | N/A | N/A | N/A |
| Last 10 Financial years | N/A | N/A | N/A |
| P/E (TTM) | 21.24 |
| P/E Before Unusual Items (TTM) | 21.24 |
| P/BV | 4.95 |
| Dividend Yield | 2.18 % |
| Market Cap. (M) | 2,060.00 |
| Return on Average Assets | 17.23 % |
| Return on Average Equity | 24.73 % |
Be the first to comment
Comments Analysis: